InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: None

Tuesday, 07/02/2019 1:23:33 AM

Tuesday, July 02, 2019 1:23:33 AM

Post# of 34625
So I have done some research on MRKR. Many are questioning the pancreatic cancer data and why ASCO didn't accept the abstract submission. Most of you know but just in case some of you don't know this is why they rejected the submission.

"Trials submitted to this session are ongoing and have not reached pre-specified endpoints for analysis. As such, inclusion of results would be improper and is strictly forbidden"

https://meetings.asco.org/am/trials-progress-abstract-submission-guidelines

They wanted to release clinical data and it wasn't allowed. However, it caused the stock to tank by 11% at that time and the price had been lower soon after that. I guess it created a nice buying opportunity though IMO.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News